Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.

Barba, Pere

Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials. [electronic resource] - European journal of haematology Jan 2019 - 79-86 p. digital

Publication Type: Clinical Trial; Journal Article

1600-0609

10.1111/ejh.13178 doi


Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Combined Modality Therapy
Consolidation Chemotherapy
Female
Genetic Testing
Hematopoietic Stem Cell Transplantation
Humans
Immunophenotyping
Induction Chemotherapy
Male
Middle Aged
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--diagnosis
Recurrence
Risk Factors
Transplantation, Homologous
Treatment Outcome
Young Adult